PubMed Health⌕ Search

Biomedical subjects

Mark H Sanders

Publications and source records attributed to Mark H Sanders.

13 recordsLinked to original sources

Sleep monitoring in children during neuromuscular blockade in the pediatric intensive care unit: a pilot study.

BACKGROUND: Sleep is an important physiologic process that is known to be disrupted in the intensive care unit. Nevertheless, there is little information on how intensive care unit admission affects sleep in children. Because laryngotracheoplasty is elective but entails 5-7 days of neuromuscular blockade following surgery, children undergoing this procedure present a unique opportunity to analyze sleep during neuromuscular blockade apart from confounding variables resulting from critical illness. OBJECTIVE: To determine the feasibility of using polysomnography to assess sleep patterns in children during neuromuscular blockade. METHODS: Polysomnography recordings were obtained continuously for 4 days (96 hrs) in two children following laryngotracheoplasty. Medication administration (neuromuscular blockades, sedatives) and time of suctioning were also recorded. RESULTS: Both subjects had documented sleep. However, the proportion of time in each stage was markedly different from developmental norms, and a greater proportion of sleep occurred during the day. Furthermore, there was substantial day-night and day-to-day variability. Some rebound of consolidated sleep appeared by day 4. Sedative use varied considerably. However, neither bolus sedation administration nor endotracheal suctioning appeared to affect sleep. Few monitoring difficulties were encountered. CONCLUSIONS: Sleep can be monitored with minimal difficulty in children undergoing neuromuscular blockade in the pediatric intensive care unit. Sleep occurred throughout the day, and there was considerable fragmentation. To fully assess sleep in the intensive care unit, monitoring needs to be continuous over several days, rather than only at night or for < or =24 hrs. Further research is needed in the area to determine typical sleep patterns in children undergoing neuromuscular blockade.

Child, Preschool↗

Prevalence and predictors of nocturia in obstructive sleep apnea-hypopnea syndrome--a retrospective study.

OBJECTIVE: To determine the prevalence and predictors of pathological nocturia (PN) in patients with OSAHS. METHODS: Retrospective review of clinical and polysomnographic data obtained from patients evaluated at the Pulmonary Sleep Evaluation Center of the University of Pittsburgh Medical Center between November 1998 and September 1999. PN was defined as two or more urination events per night. OSAHS was defined as Apnea-Hypopnea Index (AHI) > or = 5. Group t-tests and Chi-square test were used to examine differences in subjects with and without PN. A multivariate approach utilizing logistic regression was performed to examine the relationships between polysomnographic variables [Arousal Index (ARI), AHI, Apnea-Hypopnea Time/Total Sleep Time x 100(%) (AHT/TST), % Total Sleep Time (TST)<90% Oxyhemoglobin Saturation (SPO2), nadir SPO2, Desaturation Event Frequency (average number of desaturations > 4% per hour sleep) (DEF)] and the presence of PN, while controlling for medical comorbidities. Data are expressed as mean + SD unless otherwise specified. Statistical significance was assessed at p < 0.05. RESULTS STUDY POPULATION: n = 138 (50 females, 88 males), age: 49.7 +/- 12.3 years, BMI [Body Mass Index (kg/m2)]: 37.7 +/- 11.3. The overall prevalence of PN was 47.8%. The prevalence of PN was greater in females (60% vs. 40.9% in males). OSAHS patients with PN had a higher prevalence of peripheral edema, higher BMI, a greater %TST < 90% SPO2, lower nadir SPO2 and greater DEF. The logistic regression model indicated that age, ARI, AHI, AHT/TST, %TST < 90%, DEF were significant predictors of PN independent of BMI, neck circumference and medical comorbidities. CONCLUSIONS: Our data confirm that PN is common in OSAHS patients. The strongest predictors are age and selected polysomnographic variables reflecting OSAHS severity.

Body Mass Index↗

Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease.

Neither the association between obstructive airways disease (OAD) and sleep apnea-hypopnea (SAH) nor the sleep consequences of each disorder alone and together have been characterized in an adult community setting. Our primary aims were (1) to determine if there is an association between OAD and SAH and (2) identify predictors of oxyhemoglobin desaturation during sleep in persons having OAD with and without SAH. Polysomnography and spirometry results from 5,954 participants in the Sleep Heart Health Study were analyzed. OAD was defined by a FEV1/FVC value less than 70%. Assessment of SAH prevalence in OAD was performed using thresholds of respiratory disturbance index (RDI) greater than 10 and greater than 15. A total of 1,132 participants had OAD that was predominantly mild (FEV1/FVC 63.81 +/- 6.56%, mean +/- SD). SAH was not more prevalent in participants with OAD than in those without OAD (22.32 versus 28.86%, with and without OAD, respectively, at RDI threshold values greater than 10; and 13.97 versus 18.63%, with and without OAD, respectively, at RDI threshold value greater than 15). In the absence of SAH, the adjusted odds ratio for sleep desaturation (> 5% total sleep time with saturation < 90%) was greater than 1.9 when FEV1/FVC was less than 65%. Participants with both OAD and SAH had greater sleep perturbation and desaturation than those with one disorder. Generally mild OAD alone was associated with minimally altered sleep quality. We conclude that (1) there is no association between generally mild OAD and SAH; (2) exclusive of SAH and after adjusting for demographic factors and awake oxyhemoglobin saturation, an FEV1/FVC value less than 65% is associated with increased risk of sleep desaturation; (3) desaturation is greater in persons with both OAD and SAH compared with each of these alone; and (4) individuals with generally mild OAD and without SAH in the community have minimally perturbed sleep.

Aged↗

Developmental stages of sleep from birth to adolescence, common childhood sleep disorders: overview and nursing implications.

Sleep is an important physiological process with profound impact on the body. Sleep undergoes normal developmental changes and common sleep problems are seen in general pediatric practice. This article discusses normal developmental changes related to sleep, common sleep disorders experienced by children and how nurses can assist parents in coping with these changes and disorders.

Adolescent↗

Sleep disordered breathing may not be an independent risk factor for diabetes, but diabetes may contribute to the occurrence of periodic breathing in sleep.

OBJECTIVE(S): (a) To determine if self-reported diabetes mellitus is independently associated with sleep-disordered breathing (SDB); (b) to determine if diabetes mellitus is specifically associated with central sleep apnea including periodic breathing (Cheyne-Stokes breathing pattern) during sleep. STUDY POPULATION: The study population reflected participants in the on-going Sleep Heart Health Study (SHHS). Analyses were conducted utilizing data obtained from 4872 SHHS participants without prevalent cardiovascular disease (CVD) and 1002 participants with self-reported CVD, defined as hospitalization for non-fatal coronary heart disease, congestive heart failure, myocardial infarction, coronary artery bypass graft, and stroke. METHODS: SHHS methodologies have been previously reported and include performance of overnight, in-home polysomnography (PSG), which recorded variables reflecting sleep architecture and breathing, permitting identification of obstructive and central apneas, hypopneas, periodic breathing and oxyhemoglobin saturation (SpO(2)). Anthropomorphic metrics as well as systemic blood pressure measurements were obtained at the time of PSG. Other health data were available from questionnaires and the data sets of the parent cohorts from whom SHHS participants were recruited. The investigators assessed and compared breathing parameters, sleep architecture and CVD variables in diabetic and non-diabetic participants. The relationships between diabetes and the various study parameters, independent of potential confounders, were examined by multivariable modeling. Linear regression modeling was employed to examine the relationship between continuously distributed variables such as respiratory disturbance index log (RDI). The relationships between diabetes and dichotomous outcome variables such as central apnea index (CAI), obstructive apnea index (OAI), periodic breathing and the percentage of time spent at various levels below SpO(2) 90% were examined by the logistic regression model. Age, gender, race, BMI and neck circumference were forced into all multivariable analyses since these factors are associated with both diabetes mellitus and SDB. RESULTS: The investigators reported that the prevalence of CVD risk factors including increased BMI, waist circumference, neck circumference, triglycerides, reduced HDL cholesterol and hypertension was greater in diabetic than non-diabetic participants. Native Americans represented a disproportionately high percentage of the diabetic population. Unadjusted data obtained from participants without prevalent CVD indicated that the mean RDI was higher in the diabetic participants. Moreover, there was a greater percentage of diabetic participants in the higher RDI categories (e.g. 23.8% of the 470 diabetics and 15.6% of the 4402 non-diabetics had RDI>15, P<0.001). Similarly, the unadjusted data indicated that a significantly greater proportion of the diabetic participants spent >5% and >10% of sleep time below SpO(2) 90%, compared with the non-diabetic participants. The unadjusted data from participants without prevalent CVD indicated that the diabetic and non-diabetic participants did not differ with regard to distribution by category of OAI severity (e.g. > or =2 events/h, > or =3 events/h, or > or =4 events/h). On the other hand, although the prevalence of central apneas was low, a significantly greater proportion of diabetic participants were in the CAI categories (> or =2 events/h and > or =3 events/h) than non-diabetic subjects. There was no difference between diabetic and non-diabetic individuals with regard to CAI prevalence in the > or =4 events/h category. Of note, a greater percentage of diabetic patients exhibited periodic breathing (3.8% vs. 1.8%, diabetic and non-diabetic participants, respectively, P=0.002). Repeating the above analyses with inclusion of the participants with prevalent CVD did not change these relationships, and in fact, the differences between diabetic and non-diabetic participants with respect to central events and periodic breathing became more evident (the data forre evident (the data for this were not provided in the paper). Linear regression analyses demonstrated that BMI, age and male gender were independently related to increased RDI among participants without prevalent CVD. Furthermore, after adjusting for age, gender, race, BMI and neck circumference, there was no difference in geometric mean RDI between the diabetic and non-diabetic participants. The adjusted odds of having RDI> or =15 and the adjusted odds for spending> or =5% or > or =10% of sleep time with SpO(2) <90% did not differ between the diabetic and non-diabetic individuals. The investigators also examined sleep architecture in the study cohort. There were no differences between the diabetic and non-diabetic groups with regard to the adjusted proportion of time spent in non-REM sleep stages, although the mean percent time spent in REM sleep was 1.1% less in the diabetic individuals. The findings were the same with or without inclusion of participants with known CVD. Even after adjustment for potential confounders, in a sample without or with prevalent CVD, diabetic participants had increased adjusted odds for periodic breathing odds ratio (1.8, 95% confidence interval (CI) with a range of 1.02--3.15 in diabetic participants without prevalent CVD vs. 1.74, 95% CI with a range of 1.16--2.62 in diabetic participants with prevalent CVD). There was a suggestion of increased odds for CAI in diabetic subjects when analyzing populations with and without prevalent CVD. CONCLUSION: The authors concluded that diabetes mellitus is associated with sleep apnea but that this association is largely explained by risk factors in common for both disorders, most notably obesity. After adjusting for confounding factors there was no difference between diabetic and non-diabetic participants with regard to obstructive events. However, even after adjusting for potential confounders, there was a greater prevalence of periodic breathing in diabetic subjects. Although not reaching statistical significance, there was a suggestion of an increased prevalence of central events in the diabetic population, particularly when the sample included participants with known CVD. The investigators believed it unlikely that the findings were attributable to underlying congestive heart failure in as much as the diabetic subjects without prevalent CVD exhibited increased prevalence of periodic breathing and possibly increased central events. The authors proposed that diabetes mellitus might be a cause of SDB, mediated through autonomic neuropathy that may alter ventilatory control mechanisms. In this context, the authors commented that autonomic neuropathy may cause perturbations in ventilatory control by altering chemoreceptor gain or altering cardiovascular function (although the authors discounted underlying congestive heart failure as an explanation for the higher prevalence of periodic breathing in diabetic participants). To reinforce their conclusions, the authors cited the literature indicating increased prevalence of sleep apnea in diabetic patients with autonomic dysfunction, as well as the association between Shy--Drager syndrome, in which autonomic insufficiency is a constitutive element, and central sleep apnea.

Journal Article↗

The efficacy of split-night sleep studies.

Positive airway pressure (PAP) therapy is the most commonly used medical modality to reverse the apneas, hypopneas and inspiratory flow-limited breaths which result in the oxyhemoglobin desaturation, altered sleep architecture, and daytime sleepiness representing the cardinal features of obstructive sleep apnea/hypopnea (OSA/H). Identifying optimal strategies to develop the initial positive airway prescription is of paramount importance to clinicians who evaluate patients with suspected OSA/H. In addition, with the growing appreciation of the clinical and physiologic importance of sleep-disordered breathing, there have been increasing demands on clinical resources to diagnose and treat these patients. The time, hardware, and personnel-intensive nature of in-laboratory polysomnography (PSG) are significant in light of the traditional paradigm that utilizes a full night PSG for a diagnostic evaluation and when indicated, another full night for PAP titration. Efforts to identify time and resource-conserving alternatives to this paradigm have focused on in-laboratory split-night studies, in which the diagnosis of OSA/H can be made, and a positive pressure prescription defined during a single overnight PSG. Case-control studies indicate that, when certain guidelines are applied, split-night PSGs result in prescription efficacy and patient adherence, which are comparable to the traditional two-night strategy. However, prospective, randomized trials designed with adequate power are required to further define the impact of a split-night strategy on clinical outcome. As more information becomes available regarding the factors that determine long-term adherence to positive pressure therapy, the potential for efficient, expeditious treatment, and cost savings with split-night sleep studies will likely receive greater attention.

Disorders of Excessive Somnolence↗

High-altitude-related disorders--Part I: Pathophysiology, differential diagnosis, and treatment.

As increasing numbers of people choose to sojourn or retire to the mountains, high-altitude illness is becoming a pathological phenomenon about which healthcare providers should have greater awareness. Hypoxia is the primary cause of high-altitude illness, but other stressors on the sympathetic nervous system, such as cold and exertion, also contribute to disease development and progression. Although variable across persons, symptoms of high-altitude disorders usually occur at altitudes over 7000 feet, and typically in 1 of 3 forms: acute mountain sickness (AMS), high-altitude cerebral edema (HACE), or high-altitude pulmonary edema (HAPE). Major symptoms include nausea, poor sleep, headache, lassitude, cough, dyspnea on exertion and at rest, ataxia, and mental status changes. As a rule, illness occurring at high altitude should be attributed to the altitude until proven otherwise. Treatment is best accomplished by descent and by oxygen or pharmacologic intervention if necessary. Under no circumstances should a person with worsening symptoms of high-altitude illness delay descent. As will be discussed in part II of this article, gradual ascent and subsequent acclimatization to altitude is the most effective prevention, though acetazolamide (Diamox) may be a useful prophylactic measure in some.

Acetazolamide↗

High-altitude-related disorders--Part II: prevention, special populations, and chronic medical conditions.

This second section of a 2-part review on high-altitude-related disorders focuses on strategies for prevention of high-altitude illness, identification of populations at increased risk for high-altitude illness, and effects of high altitude on selected chronic medical conditions. Practical aspects of advising and educating patients traveling to high altitude will be discussed, with special reference to pregnant women, infants and young children, healthy elders, and chronic medical conditions that may place persons at greater risk for high-altitude illness. The special concerns of pre-verbal children will be covered relative to the risks of high altitude for those too young to voice symptoms of illness and, thus, at-risk for potential serious consequences caused by delay in diagnosis and treatment.

Age Factors↗